Amine Ahmami

Amine Ahmami is a Researcher at Erasmus MC, specializing in pancreatic cancer therapeutics and evidence synthesis. His primary institutional affiliation is with the Erasmus University Medical Center in Rotterdam.

His research focuses on clinical oncology with emphasis on pancreatic cancer treatment optimization, particularly through systematic reviews and meta-analyses of chemotherapy protocols. Key areas include first-line chemotherapy regimens, pancreatic adenocarcinoma management, and CA 19-9 antigen monitoring. Current work examines chemotherapy switching strategies for localized disease.

Recent publication trends show concentrated expertise in evidence-based oncology, with significant contributions to meta-analytical methodology in gastrointestinal cancers. His 2024 British Journal of Surgery publication demonstrates rigorous synthesis of clinical trial data for pancreatic cancer therapeutics.

Ongoing research collaborations span multiple international institutions as evidenced by multi-center authorship on recent publications. Current projects appear focused on optimizing neoadjuvant chemotherapy sequences and biomarker-driven treatment selection.